Forte Biosciences, Inc. (FBRX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2015: -$22.95M2016: -$31.69M2017: -$37.63M2018: -$45.85M2019: -$4.06M2020: -$46.28M2021: -$21.49M2022: -$13.90M2023: -$32.49M2024: -$36.60M2025: -$70.66M-$70.66M
2015Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$70.66M-93.0%
2024-$36.60M-12.7%
2023-$32.49M-133.8%
2022-$13.90M+35.3%
2021-$21.49M+53.6%
2020-$46.28M-1038.8%
2019-$4.06M+91.1%
2018-$45.85M-21.9%
2017-$37.63M-18.7%
2016-$31.69M-38.1%
2015-$22.95M